Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c3a20f096a111d7da75b0e026981d04 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-215 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-198 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-22 |
filingDate |
2004-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_902689d745a6eac3cf730ed43039fc00 |
publicationDate |
2006-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2006173078-A1 |
titleOfInvention |
Method of treatment or prophylaxis of symptoms of herpes viral infection |
abstract |
A method providing the treating or prophylaxis of one or more symptoms of viral infection. The method involving the administration of citrate and/or succinate salts. The present invention also encompasses the use of citrate and/or succinate salts for the treatment of prevention of lesions or blisters, or other symptoms of infection by members of the herpes virus family. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11278507-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007135525-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8415398-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012225143-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9283198-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004254248-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018048609-A1 |
priorityDate |
2003-01-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |